At a glance
The October 19, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on COVID-19 test reporting tool, effects of increased SARS-CoV-2 testing, CDC's use of COVID-19 testing data, and an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
National Healthcare Safety Network (NHSN) Point-of-Care Test Reporting Tool for COVID-19 in Long-Term Care Facilities: Kathy Bridson, CDC Division of Healthcare Quality Promotion (DHQP)
2020-2021 Influenza Testing Issues: Tim Uyeki, CDC Influenza Division (ID)
Effects of Increased SARS-CoV-2 Testing on Laboratory Services: An Emerging Infections Network (EIN) Survey: Dan Diekema, University of Iowa
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
How Does CDC Use COVID-19 Laboratory Testing Data?: Jason Hall, CDC Division of Preparedness and Emerging Infections (DPEI) and Ed Lockhart, CDC Division of Laboratory Systems (DLS)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.